CGG: CGG Announces its 2020 Second Quarter Results
CGG Announces its 2020 Second Quarter ResultsA quarter impacted by Covid-19 and oil price dropBay Street News
Arcturus Therapeutics Announces Pricing of $173.0 Million Public Offering of Common Stock
SAN DIEGO, July 29, 2020 (GLOBE NEWSWIRE) — Arcturus Therapeutics Holdings Inc. (the “Company”, NASDAQ: ARCT), a leading clinical-stage messenger […]
Euronet Worldwide Reports Second Quarter 2020 Financial Results
LEAWOOD, Kansas, July 29, 2020 (GLOBE NEWSWIRE) — Euronet Worldwide, Inc. (“Euronet” or the “Company”) (NASDAQ: EEFT), a leading electronic […]
QuestCap Signs Definitive Agreement and Closes Transaction to Acquire 28% Interest in Colombian Full-Service Medical Clinic
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, July 28, 2020 (GLOBE NEWSWIRE) […]
TCR² Therapeutics Announces Pricing of Public Offering of Common Stock
CAMBRIDGE, Mass., July 28, 2020 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR) (“TCR2” or the “Company”), a clinical-stage immunotherapy […]
Gran Tierra Announces Release Date for its 2020 Second Quarter Results, Conference Call and Webcast Details
CALGARY, Alberta, July 28, 2020 (GLOBE NEWSWIRE) — Gran Tierra Energy Inc. (“Gran Tierra”) (NYSE American:GTE) (TSX:GTE) (LSE:GTE), announces that […]
Aurcana Closes Second and Final Tranche of Previously Announced Non-Brokered Private Placement for a Total of C$12,275,700
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Bay Street News
Adaptive Biotechnologies Launches National Clinical Trial to Develop Novel T-Cell Based Diagnostic for Lyme Disease
SEATTLE, July 28, 2020 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corp. (Nasdaq: ADPT) announced today the launch of ImmuneSense Lyme™, a […]
Alector Announces Promising Preliminary Data from AL001 Phase 1b and Phase 2 Open-Label Long-Term Dosing Study of People with Frontotemporal Dementia
AL001 was generally safe and well-tolerated in Phase 1b study and after continuous dosing in 15 asymptomatic and symptomatic FTD-GRN […]
TSX News -
Resverlogix Announces Extension of its Filing Calendar Based on Continuous Disclosure Exemption
CALGARY, Alberta, July 28, 2020 (GLOBE NEWSWIRE) — Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX:RVX) announces that it intends to […]
